MY Terzi - Journal of Clinical Practice and Research, 2023 - jag.journalagent.com
Objective: Propranolol (PRO), a non-selective beta-adrenergic receptor inhibitor, has been
recently discovered to possess anti-tumorigenic effects in cancer patients. Therefore, we …